نتائج البحث

Investigating the dose-response relationship between music and anxiety reduction: A randomized clinical trial

• Authors : Danielle K. Mullen; Tianle Peng; Lauren Stewart

Subjects: Music therapy; anxiety; therapy

تفاصيل العنوان

A Pragmatic Randomized clinical trial: twice-weekly vs. thrice-weekly Incident hemoDialysis in Elderly patients (PRIDE): study protocol

• Authors : Han, Miyeun; Jeon, Huiwon; Yu, Byung Chul ...

Subjects: QUALITY-OF-LIFE; KIDNEY-DISEASE; OLDER-ADULTS

تفاصيل العنوان

Clinical trial transparency: timely results reporting and threaded evidence to increase value and reduce waste in biomedical research

• Authors : Salholz-Hillel, Maia

Subjects: Medizin

• Source: Salholz-Hillel, Maia: Clinical trial transparency: timely results reporting and threaded evidence to increase value and reduce waste in

تفاصيل العنوان

Presentation 3_A phase 2a double-blind, placebo-controlled, randomized clinical trial evaluating the efficacy and safety of NuGel, a novel topical GPCR19-mediated inflammasome inhibitor, in patients with mild to moderate atopic dermatitis: a proof-of-concept study with Post-hoc biomarker analysis.pptx

• Authors : Gyeong Ho Baek; Bo Ri Kim; Jung-Won Shin

Subjects: Genetic Immunology; atopic dermatitis; GPCR19

تفاصيل العنوان

Presentation 2_A phase 2a double-blind, placebo-controlled, randomized clinical trial evaluating the efficacy and safety of NuGel, a novel topical GPCR19-mediated inflammasome inhibitor, in patients with mild to moderate atopic dermatitis: a proof-of-concept study with Post-hoc biomarker analysis.zip

• Authors : Gyeong Ho Baek; Bo Ri Kim; Jung-Won Shin

Subjects: Genetic Immunology; atopic dermatitis; GPCR19

تفاصيل العنوان

Presentation 1_A phase 2a double-blind, placebo-controlled, randomized clinical trial evaluating the efficacy and safety of NuGel, a novel topical GPCR19-mediated inflammasome inhibitor, in patients with mild to moderate atopic dermatitis: a proof-of-concept study with Post-hoc biomarker analysis.pptx

• Authors : Gyeong Ho Baek; Bo Ri Kim; Jung-Won Shin

Subjects: Genetic Immunology; atopic dermatitis; GPCR19

تفاصيل العنوان

Presentation 2_A phase 2a double-blind, placebo-controlled, randomized clinical trial evaluating the efficacy and safety of NuGel, a novel topical GPCR19-mediated inflammasome inhibitor, in patients with mild to moderate atopic dermatitis: a proof-of-concept study with Post-hoc biomarker analysis.zip

• Authors : Gyeong Ho Baek; Bo Ri Kim; Jung-Won Shin

Subjects: Genetic Immunology; atopic dermatitis; GPCR19

تفاصيل العنوان

Presentation 3_A phase 2a double-blind, placebo-controlled, randomized clinical trial evaluating the efficacy and safety of NuGel, a novel topical GPCR19-mediated inflammasome inhibitor, in patients with mild to moderate atopic dermatitis: a proof-of-concept study with Post-hoc biomarker analysis.pptx

• Authors : Gyeong Ho Baek; Bo Ri Kim; Jung-Won Shin

Subjects: Genetic Immunology; atopic dermatitis; GPCR19

تفاصيل العنوان

Presentation 1_A phase 2a double-blind, placebo-controlled, randomized clinical trial evaluating the efficacy and safety of NuGel, a novel topical GPCR19-mediated inflammasome inhibitor, in patients with mild to moderate atopic dermatitis: a proof-of-concept study with Post-hoc biomarker analysis.pptx

• Authors : Gyeong Ho Baek; Bo Ri Kim; Jung-Won Shin

Subjects: Genetic Immunology; atopic dermatitis; GPCR19

تفاصيل العنوان

Understanding Associations Between Patient‐Level Factors and Participation in a Breast Cancer Clinical Trial

• Authors : Caston, Nicole E.; Deng, Luqin; Williams, Courtney P.

Subjects: effect; associated with trial participation; patients

• Source: Cancer Medicine, 14(16)

تفاصيل العنوان